Skip to main content
Veterinary Medicines

GALLIMUNE 201 IBD + REO

Authorised
  • Avian reovirus, strain 1733, Inactivated
  • Infectious bursal disease virus, strain VNJO, Inactivated

Product identification

Medicine name:
GALLIMUNE 201 IBD + REO
Active substance:
  • Avian reovirus, strain 1733, Inactivated
  • Infectious bursal disease virus, strain VNJO, Inactivated
Target species:
  • Chicken (layer hen)
  • Chicken (for reproduction)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Avian reovirus, strain 1733, Inactivated
    7.00
    log10 50% cell culture infectious dose
    /
    1.00
    Dose
  • Infectious bursal disease virus, strain VNJO, Inactivated
    5.70
    log10 50% cell culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA22
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-2180
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 24/01/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 24/01/2023

Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 24/01/2023